From hypoxia single-cell gene signatures to HIF targeting of AML leukemic stem cells
- PMID: 38560647
- PMCID: PMC10979755
- DOI: 10.1002/hem3.59
From hypoxia single-cell gene signatures to HIF targeting of AML leukemic stem cells
Conflict of interest statement
The authors have no relevant conflict of interest to declare.
Figures
Comment on
-
Integrative single-cell expression and functional studies unravels a sensitization to cytarabine-based chemotherapy through HIF pathway inhibition in AML leukemia stem cells.Hemasphere. 2024 Feb 26;8(2):e45. doi: 10.1002/hem3.45. eCollection 2024 Feb. Hemasphere. 2024. PMID: 38435427 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources